Core-007
Core-007
批准号:
9548821
负责人:
William Robert Taylor
金额:
$42.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AccelerationAreaClinicalClinical SciencesCommunitiesDevelopmentEngineeringEnvironmentFutureHealthHealth TechnologyHealthcareIndividualInstitutionInvestmentsLinkMedicalMedical DeviceMedical centerProcessReadinessResearchResearch PersonnelResourcesScientistTechnologyTestingTranslational ResearchUnderrepresented MinorityWomancatalystdesigndigitalinnovationinterestnovelpopulation healthprogramsscience educationskills
中文摘要
GaCTSA创新催化剂功能旨在利用与非营利组织的独特合作伙伴关系
乔治亚州和东南部的技术组织,并提供与内部现有优势的无缝链接
GaCTSA合作机构,目的是加速研究翻译。临床医生、科学家和
学术环境中的工程师对医疗保健创新越来越感兴趣
人口健康管理,许多人被该地区日益增长的数字健康和
科技创新中心。然而,这些人通常不具备发展和发展所需的技能
将医疗技术商业化。归根结底,调查人员必须了解两个主要主题:1)
如何清楚地识别和验证真正的未得到满足的临床需求,以及2)如何对
医学发展过程的基本原理。通过GaCTSA合作者和其他资源
如佐治亚州研究联盟、GeorgiaBio和全球医疗创新中心,有
在医疗设备和数字健康开发和测试能力方面的重大投资,以帮助支持
从实验室到临床环境的整个连续体的技术。创新催化剂的职能将作为
促进者和科学教育实体,以扩大现有的伙伴关系和方案,并实施
加快卫生技术创新、吸引和发展临床医生社区的举措
企业家,并增强不同未来创新者团队的准备和可持续性
特别强调将妇女和代表性不足的少数群体包括在内。
英文摘要
The GaCTSA Innovation Catalyst Function is designed to leverage unique partnerships with non-profit
technology organizations in Georgia and the Southeast, and provide seamless links to existing strengths within
GaCTSA partner institutions for the purpose of acceleration of research translation. Clinicians, scientists, and
engineers in academic environments are increasingly interested in health care innovations required for
population health management, and many are attracted to the area’s growing strength as a digital health and
technology innovation hub. Yet these individuals generally do not have the skill sets required to develop and
commercialize health technology. Ultimately, there are two main topics that investigators must understand: 1)
How to clearly identify and validate true unmet clinical needs, and 2) How to gain a strong understanding of
fundamentals of the medical development process. Through the GaCTSA collaborators, and other resources
such as Georgia Research Alliance, GeorgiaBio, and the Global Center for Medical Innovation, there is a
significant investment in medical device and digital health development and testing capabilities to help support
technologies across the continuum from lab to clinical setting. The Innovation Catalyst Function will serve as
the facilitator and science education entity to extend existing partnerships and programs and implement novel
initiatives to accelerate health technology innovation, engage and grow the community of clinician
entrepreneurs, and enhance the preparedness and sustainability of diverse teams of future innovators with a
string emphasis on the inclusion of women and underrepresented minorities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HOWARD UNIVERSITY GENERAL CLINICAL RESEARCH CENTER
-
批准号:8167000
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:William Robert Taylor
-
依托单位:
Biology, Biomechanics and Atherosclerosis
-
批准号:7822529
-
项目类别:
-
资助金额:$1.86万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Osteopontin and Collateral Vessel Growth
-
批准号:7731048
-
项目类别:
-
资助金额:$36.17万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Catalase: a pivotal regulator of vascular disease
-
批准号:9271227
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Osteopontin and Collateral Vessel Growth
-
批准号:8088112
-
项目类别:
-
资助金额:$34.8万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Catalase: a pivotal regulator of vascular disease
-
批准号:8935386
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Osteopontin and Collateral Vessel Growth
-
批准号:7915248
-
项目类别:
-
资助金额:$34.8万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Catalase: a pivotal regulator of vascular disease
-
批准号:9100846
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Osteopontin and Collateral Vessel Growth
-
批准号:8296360
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Role of inflammatory cell RAGE in collateral vessel formation
-
批准号:7788446
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2009
-
负责人:William Robert Taylor
-
依托单位:
Hypertension, Hydrogen Peroxide and Vascular Inflammation
-
批准号:7899832
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2008
-
负责人:William Robert Taylor
-
依托单位:
HF-ACTION
-
批准号:7952042
-
项目类别:
-
资助金额:$0.48万
-
财政年份:2008
-
负责人:William Robert Taylor
-
依托单位:
Hypertension, Hydrogen Peroxide and Vascular Inflammation
-
批准号:7682311
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2008
-
负责人:William Robert Taylor
-
依托单位:
Hypertension, Hydrogen Peroxide and Vascular Inflammation
-
批准号:8116635
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2008
-
负责人:William Robert Taylor
-
依托单位:
HF-ACTION
-
批准号:7716577
-
项目类别:
-
资助金额:$0.78万
-
财政年份:2008
-
负责人:William Robert Taylor
-
依托单位:
IRPG (NOVEL PHENOTYPES)
-
批准号:7607806
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2007
-
负责人:William Robert Taylor
-
依托单位:
MALT LIQUOR
-
批准号:7607808
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2007
-
负责人:William Robert Taylor
-
依托单位:
Vascular specific ACE expression and atherosclerosis
-
批准号:7409084
-
项目类别:
-
资助金额:$48.4万
-
财政年份:2007
-
负责人:William Robert Taylor
-
依托单位:
HF-ACTION
-
批准号:7606883
-
项目类别:
-
资助金额:$2.01万
-
财政年份:2006
-
负责人:William Robert Taylor
-
依托单位:
IRPG (NOVEL PHENOTYPES)
-
批准号:7378661
-
项目类别:
-
资助金额:$14.88万
-
财政年份:2006
-
负责人:William Robert Taylor
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: